-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Amneal Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2018 to 2023.
- Amneal Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 319M shares, a 106% increase year-over-year.
- Amneal Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 176M shares, a 16.7% increase from 2022.
- Amneal Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 151M shares, a 0.58% decline from 2021.
- Amneal Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 152M shares, a 1.95% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)